Related references
Note: Only part of the references are listed.Pharmacokinetic modeling of intravenous sildenafil in newborns with congenital diaphragmatic hernia
Suzan C. M. Cochius-den Otter et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology
Lenneke Schrier et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
Population pharmacokinetics of sildenafil in extremely premature infants
Daniel Gonzalez et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants
N. Thakkar et al.
JOURNAL OF PERINATOLOGY (2016)
Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
Tewodros Eguale et al.
JAMA INTERNAL MEDICINE (2016)
Precision Dosing in Children
Daniel B. Hawcutt et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2016)
Sildenafil in pediatric pulmonary arterial hypertension
A. K. Dhariwal et al.
JOURNAL OF POSTGRADUATE MEDICINE (2015)
Dosing in Children: A Critical Review of the Pharmacokinetic Allometric Scaling and Modelling Approaches in Paediatric Drug Development and Clinical Settings
Iftekhar Mahmood
CLINICAL PHARMACOKINETICS (2014)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Robyn J. Barst et al.
CIRCULATION (2012)
Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube
Maurice J. Ahsman et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2010)
Neonatal pulmonary hypertension
Robin H. Steinhorn
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Clinical use of sildenafil in pulmonary artery hypertension
TP Singh
Expert Review of Respiratory Medicine (2010)
Population Pharmacokinetics of Sildenafil in Term Neonates: Evidence of Rapid Maturation of Metabolic Clearance in the Early Postnatal Period
A. Mukherjee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
David J. Waxman et al.
MOLECULAR PHARMACOLOGY (2009)
Sildenafil for the Treatment of Pulmonary Hypertension in Pediatric Patients
Alice J. Huddleston et al.
PEDIATRIC CARDIOLOGY (2009)
Definition, Classification, and Epidemiology of Pulmonary Arterial Hypertension
Marius M. Hoeper
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Advances in therapies for pediatric pulmonary arterial hypertension
Cecile Tissot et al.
Expert Review of Respiratory Medicine (2009)
The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
N. Mehrotra et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2007)
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Hossein A. Ghofrani et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Developmental expression of human hepatic CYP2C9 and CYP2C19
SB Koukouritaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension
HH Leuchte et al.
CHEST (2004)
The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil citrate
GJ Muirhead et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Now important are gender differences in pharmacokinetics?
B Meibohm et al.
CLINICAL PHARMACOKINETICS (2002)
Share Paper
